T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Bentley Systems
BSY
$11B
| $7.5M | ﹤0.01% |
169,705
+6,465
| +4% | +$258K |
|
1402
Carlisle Companies
CSL
$14.7B
| $7.46M | ﹤0.01% |
30,323
+3,713
| +14% | +$870K |
|
1403
Sunrun
RUN
$2.42B
| $7.44M | ﹤0.01% |
245,005
+47,273
| +24% | +$1.32M |
|
|
WHWK
1404
Whitehawk Therapeutics
WHWK
$253M
| $7.4M | ﹤0.01% |
435,951
-72,941
| -14% | -$1.4M |
|
1405
W.P. Carey
WPC
$16.3B
| $7.35M | ﹤0.01% |
92,820
-242,672
| -72% | -$18.6M |
|
1406
RB Global
RBA
$15.8B
| $7.32M | ﹤0.01% |
124,008
-60
| -0% | -$3.52K |
|
|
BLSA
1407
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $7.32M | ﹤0.01% |
741,370
+4,000
| +0.5% | +$39.4K |
|
1408
Aramark
ARMK
$16.3B
| $7.15M | ﹤0.01% |
263,529
-7,621
| -3% | -$199K |
|
1409
Protagonist Therapeutics
PTGX
$9.93B
| $7.12M | ﹤0.01% |
300,468
-76,664
| -20% | -$2.16M |
|
1410
HEICO Corp Class A
HEI.A
$38.1B
| $6.87M | ﹤0.01% |
54,175
-337
| -0.6% | -$40.8K |
|
1411
Ciena
CIEN
$59.9B
| $6.86M | ﹤0.01% |
113,103
+3,762
| +3% | +$246K |
|
1412
Sensata Technologies
ST
$6.67B
| $6.74M | ﹤0.01% |
132,504
+4,744
| +4% | +$270K |
|
|
EQRX
1413
DELISTED
EQRx, Inc. Common Stock
EQRX
| $6.59M | ﹤0.01% |
1,596,123
-976,450
| -38% | -$4.25M |
|
1414
Dell
DELL
$317B
| $6.57M | ﹤0.01% |
130,922
+13,168
| +11% | +$735K |
|
|
INFA
1415
DELISTED
Informatica
INFA
| $6.55M | ﹤0.01% |
331,588
-7,478
| -2% | -$180K |
|
|
USX
1416
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $6.48M | ﹤0.01% |
1,671,031
-9,274
| -0.6% | -$41.6K |
|
|
AKRO
1417
DELISTED
Akero Therapeutics
AKRO
| $6.46M | ﹤0.01% |
455,364
-704,166
| -61% | -$12.3M |
|
1418
Royal Bank of Canada
RY
$299B
| $6.38M | ﹤0.01% |
57,874
+1,745
| +3% | +$196K |
|
1419
AMC Entertainment Holdings
AMC
$2.25B
| $6.36M | ﹤0.01% |
25,819
+1,109
| +4% | +$206K |
|
1420
MoonLake Immunotherapeutics
MLTX
$1.41B
| $6.29M | ﹤0.01% |
566,191
-180,671
| -24% | -$1.8M |
|
1421
Lyft
LYFT
$6.56B
| $6.24M | ﹤0.01% |
162,455
+9,281
| +6% | +$363K |
|
1422
Coinbase
COIN
$39.9B
| $6.18M | ﹤0.01% |
32,557
+23,617
| +264% | +$4.61M |
|
1423
Teva Pharmaceuticals
TEVA
$42.7B
| $6.11M | ﹤0.01% |
650,715
+116,033
| +22% | +$968K |
|
1424
Warner Bros
WBD
$69.6B
| $6.04M | ﹤0.01% |
242,215
+8,569
| +4% | +$235K |
|
1425
Artesian Resources
ARTNA
$367M
| $6.01M | ﹤0.01% |
123,847
+116,587
| +1,606% | +$5.44M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.